Skip to main content
. 2021 Dec 24;11:745085. doi: 10.3389/fonc.2021.745085

Table 2.

Univariate and multivariate logistic regression analysis of prediction of MVI in training cohort.

Characteristics Univariate Logistic regression analysis Multivariate Logistic regression analysis
OR (95%CI) P-value OR(95%CI) P-value
Gender Male vs Female 1.385 (0.730, 2.626) 0.318
Age (years) ≥65 vs <65 1.757 (0.974, 3.169) 0.061
With hepatitis Present vs Absent 1.284 (0.682, 2.418) 0.439
With Cirrhosis Present vs Absent 1.399 (0.784, 2.496) 0.255
AFP (ng/ml) >400 vs ≤400 4.405 (2.581, 7.518) <0.001 4.327 (1.803, 10.384) 0.001
AST (U/L) <45
45–90 vs <45
>90 vs <45
Control
2.564 (1.419, 4.633)
4.555 (1.735, 11.958)
<0.001
0.002
0.002
0.195
ALT (U/L) <40
40–80 vs <40
>80 vs <40
Control
1.024 (0.592, 1.770)
1.660 (0.773, 3.567)
0.420
0.933
0.194
Total bilirubin (umol/L) >17.1 vs ≤17.1 1.216 (0.750, 1.970) 0.428
Direct bilirubin (umol/L) >3.4 vs ≤3.4 1.302 (0.751, 2.258) 0.347
Total protein (g/L) <65 vs ≥65 1.461 (0.901, 2.370) 0.124
Serum albumin (g/L) <40 vs ≥40 1.077 (0.662, 1.754) 0.764
Neutrophils (109/L) >6.30 vs ≤6.30 1.081 (0.521, 2.241) 0.835
Platelet (109/L) <125 vs ≥125 1.151 (0.708, 1.871) 0.571
Lymphocyte (109/L) <1.10 vs ≥1.10 3.267 (1.965, 5.432) <0.001 2.747 (1.193, 6.328) 0.018
VEGF-A (pg/ml) >138.30 vs ≤138.30 21.125 (11.264, 39.619) <0.001 33.088 (12.871, 85.057) <0.001
Tumor size (cm) <3
3–5 vs <3
>5 vs <3
Control
1.071 (0.490, 2.344)
5.523 (2.687, 11.312)
<0.001
0.863
<0.001
0.954
Peritumoral enhancement Present vs Absent 7.725 (4.473, 13.341) <0.001 2.415(1.009, 5.781) 0.048
Peritumoral boundary Clear boundaryvs Unclear boundary 3.062 (1.832, 5.119) <0.001 0.502
Tumor shape Regular shape
vs Irregular shape
5.468 (3.173, 9.425) <0.001 3.504(1.478, 8.307) 0.004
Intratumoral artery Present vs Absent 12.508 (7.004, 22.337) <0.001 7.121(2.830, 17.922) < 0.001
Multiple tumors Present vs Absent 2.712 (1.019, 7.220) 0.046 0.084